Hirotaka Nagashima
Department of Cardiology
The Heart Institute of Japan
Second Department of Medicine
Tokyo Women's Medical University
Japan
Name/email consistency: medium
- Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall. Nagashima, H., Aoka, Y., Sakomura, Y., Uto, K., Sakuta, A., Aomi, S., Kurosawa, H., Hagiwara, N., Kawana, M., Kasanuki, H. J. Vasc. Surg. (2004)
- Therapeutic value of statins for vascular remodeling. Nagashima, H., Kasanuki, H. Curr. Vasc. Pharmacol (2003)
- An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats. Nagashima, H., Uto, K., Sakomura, Y., Aoka, Y., Sakuta, A., Aomi, S., Hagiwara, N., Kawana, M., Kasanuki, H. J. Vasc. Surg. (2002)
- Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome. Nagashima, H., Sakomura, Y., Aoka, Y., Uto, K., Kameyama Ki, , Ogawa, M., Aomi, S., Koyanagi, H., Ishizuka, N., Naruse, M., Kawana, M., Kasanuki, H. Circulation (2001)